Adaptin Bio, Inc.
APTN
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 210.00% | 187.28% | 1,334.39% | 682.04% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 169.24% | 68.45% | 98.21% | 183.78% | |
| Operating Income | -169.24% | -68.45% | -98.21% | -183.78% | |
| Income Before Tax | -59.66% | -51.28% | -85.77% | -77.70% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -59.66% | -51.28% | -85.77% | -77.70% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -59.66% | -51.28% | -85.77% | -77.70% | |
| EBIT | -169.24% | -68.45% | -98.21% | -183.78% | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 38.81% | 41.84% | 28.58% | 0.86% | |
| Normalized Basic EPS | 20.88% | 41.83% | 28.59% | -52.68% | |
| EPS Diluted | 38.58% | 41.31% | 28.54% | 0.86% | |
| Normalized Diluted EPS | 20.88% | 41.83% | 28.59% | -52.68% | |
| Average Basic Shares Outstanding | 161.01% | 160.18% | 160.14% | 79.29% | |
| Average Diluted Shares Outstanding | 161.01% | 160.18% | 160.14% | 79.29% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |